Posts With Tag baxdrostat

Baxdrostat by AstraZeneca shows significant blood pressure reduction in Phase III trial, advancing treatment for resistant hypertension. Promising results showcase its safety and effectiveness.

AstraZeneca's Baxdrostat shows significant promise in treating uncontrolled hypertension, marking a major advancement in cardiovascular medicine.